FDA Inspection 988662 — Hubei Haosun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Haosun Pharmaceutical Co., Ltd. on September 2, 2016 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 2, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)